Published: 2020-04-24

Comparison of outcome of milwaukee regimen and 48 hours regimen in diabetic ketoacidosis in a tertiary care hospital in Chitradurga, Karnataka, India

Basavanthappa S. P., Srinivasa V., Sivachand T.


Background: Diabetic ketoacidosis (DKA) is an acute life threatening and a medical emergency that accounts for the majority of diabetes related mortality and morbidity in the pediatric age group who are suffering from type 1 Diabetes Mellitus (DM). Objective of this study was to compare the clinical outcome in a patient with DKA who are been treated with Milwaukee regimen (24hours) and 48 hours regimen.

Methods: A retrospective study was conducted in PICU of tertiary care hospital in Chitradurga, Karnataka. Data was collected from 2015 to May 2018. Diagnosis of DKA was made by plasma glucose level higher than 200mg/dl, venous blood PH of <7.3 and /or bicarbonate <15 mmol/L, presence of ketonuria. Among 56 cases, 36 cases were treated with 48 hours regimen and 20 cases were treated with Milwaukee regimen and results were compared.

Results: The median age of presentation was 7.52 years (Range: 2-14 years) with female: male ratio of 1:1.3. Newly diagnosed type 1 DM cases constituted 80.7%. The most common presenting complaints were hurried breathing and altered sensorium. The average length of stay in the ICU was 3.5 days for 48 hours regimen and 4.5 days for Milwaukee regimen. The mortality rate was 10.71 % (6 cases), among which 15% (3 cases) were patients treated with Milwaukee and 8.3% (3 cases) were patients treated with 48 hours regimen. Cerebral edema was found to be the commonest cause of fatality.

Conclusions: There is lack of awareness regarding dog bite and its management among the rural population.


Cerebral edema, Diabetic ketoacidosis, Diabetes mellitus, Milwaukee regimen

Full Text:



Edge J, Ford-Adams M, Dunger D. Causes of death in children with insulin-dependent diabetes 1990-96. Arch Dis Child. 1999;81:318-23.

Dunger DB, Sperling MA, Acerini CL, Bohn DJ, Daneman D, Danne TP, et al. European Society for Pediatric Endocrinology/Lawson Wilkins pediatric endocrine society consensus statement on diabetic ketoacidosis in children and adolescents. Pediatr. 2004;113:e133-40.

Wolfsdorf J, Glaser N, Sperling MA. Diabetic ketoacidosis in infants, children, and adolescents. A consensus statement from the American Diabetes Association. Diab Care. 2006;29:1150-9.

Umpierrez GE, Khajavi M, Kitabchi AE. Review: diabetic ketoacidosis and hyperglycemic hyperosmolar nonketotic syndrome. Am J Med Sci. 1996;311:225-33.

Curtis JR, To T, Muirhead S, Cummings E, Daneman D. Recent trends in hospitalization for diabetic ketoacidosis in Ontario children. Diabetes Care. 2002;25:1591-6.

Ganesh R, Suresh N, Ramesh J. Diabetic ketoacidosis in children. Natl Med J India. 2006;19:155-8.

Glaser N, Barnett P, McCaslin I, Nelson D, Trainor J, Louie J, et al. Risk factors for cerebral edema in children with diabetic ketoacidosis. N Engl J Med. 2001;344:264-9.

Harris GD, Flordalisi I, Harris WL, Mosovich LL, Finberg L. Minimizing the risk of brain herniation during treatment of diabetic ketoacidemia: a retrospective and prospective study. J Pediatr. 1990;117:22-31.

Narins RG, Cohen JJ. Bicarbonate therapy for organic acidosis: the case for its continued use. Ann Intern Med.1987;106:615-8.

Jayashree M, Singhi S. Diabetic ketoacidosis: Predictors of outcome in a pediatric intensive care unit of a developing country. Pediatr Crit Care Med. 2004;5:427-33.

Jahagirdar RR, Khadilkar VV, Khadilkar AV, Lalwani SK. Management of diabetic ketoacidosis in PICU. Indian J Pediatr. 2007;74:551-4.

Neu A, Willasch A, Ehehalt S, Hub R, Ranke MB. Ketoacidosis at onset of type 1 diabetes mellitus in children: frequency and clinical presentation. Pediatr Diabetes. 2003;4:77-81.

Klein M, Sathasivam A, Novoa Y, Rapaport R. Recent consensus statements in pediatric endocrinology: a selective review. Endocrinol Metab Clin N Am. 2009;38:811-25.